The drug maker announced it’s cutting the price of its most commonly-used insulins by 70%, and capping patients’ out-of-pocket cost at $35 at certain participating pharmacies.
Drugmaker Eli Lilly will supply the government with another 150,000 doses of its monoclonal antibody to meet short-term demand.
Lawmakers have been critical of big pharma's pricing structures.
Eli Lilly reports the results of a trial for Alzheimer's medication.
Eli Lilly is reducing its U.S. sales force, reportedly by 30 percent. How have digital and other advertising practices changed the nature of sales?
